血液透析患者におけるホモシステインおよび非対称ジメチルアルギニンが心血管イベントに及ぼす影響

基本情報

NCT ID: NCT00161369
ステータス: 完了
試験のフェーズ: -
試験タイプ: 観察
目標被験者数: 200
治験依頼者名: University of Shizuoka

概要

Homocysteine (Hcy) and asymmetric dimethylarginine (ADMA) have recently been recognized as potential risk factors for atherosclerosis in the general population, and the metabolism of each of these substances seems to be closely related. This study investigates the association between these substances, and whether elevated serum levels of Hcy and ADMA would be related to a high risk of atherosclerosis and cardiovascular events in maintenance hemodialysis (HD) patients.

対象疾患

Chronic Renal FailureHemodialysisAtherosclerosis

依頼者（Sponsor）

Maruyama Memorial General Hospital(OTHER)

Hamamatsu University(OTHER)

University Of Shizuoka(OTHER)

実施施設 (1)

地方独立行政法人　静岡市立静岡病院

Shizuoka, Shizuoka, Japan